Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

Press releases published on June 2, 2026

Jun. 2, 2026

DBV Technologies annonce le screening du premier participant de l’étude clinique de phase 2 THRIVE pour le patch VIASKIN® Peanut chez les nourrissons âgés de 6 à 12 mois allergiques à l’arachide

Indeterminate GlobeNewswire

Jun. 2, 2026

Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine

Indeterminate GlobeNewswire

Jun. 2, 2026

Fortrea to Attend Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 2, 2026

CAHI Honours The Honourable Don Boudria for Leadership in Animal Health

Indeterminate GlobeNewswire

Jun. 2, 2026

L’ICSA rend hommage à l’honorable Don Boudria pour son engagement envers la santé animale

Indeterminate GlobeNewswire

Jun. 2, 2026

INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q

Indeterminate GlobeNewswire

Jun. 2, 2026

Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™”

Indeterminate GlobeNewswire

Jun. 2, 2026

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Indeterminate GlobeNewswire

Jun. 2, 2026

Nanobiotix Provides First Quarter 2026 Operational and Financial Update

Indeterminate GlobeNewswire

Jun. 2, 2026

Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026

Indeterminate GlobeNewswire

Jun. 2, 2026

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 2, 2026

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire

Jun. 2, 2026

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Indeterminate GlobeNewswire

Jun. 2, 2026

BriaCell Therapeutics Announces Closing of Offering

Indeterminate GlobeNewswire

Jun. 2, 2026

J-Star Holding Outlines Foundational Milestones Supporting Proposed Baytown Battery Manufacturing Facility

Indeterminate GlobeNewswire

Jun. 2, 2026

Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics

Indeterminate GlobeNewswire

Jun. 2, 2026

KORTUC Launches Global Cervical Cancer Study, Expanding Pipeline to Second Indication

Indeterminate GlobeNewswire

Jun. 2, 2026

Legend Senior Living® Expands Pennsylvania Footprint with Three Hemsley House Communities in Malvern, Dresher, and North Wales

Indeterminate GlobeNewswire